C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes

BACKGROUND: Some benefits of glucose-insulin-potassium (GIK) in patients with acute coronary syndromes (ACS) may be from an anti-inflammatory effect. The primary aim of this study was to assess the impact of GIK administration early in the course of ACS on inflammatory marker C-reactive protein (CRP...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkofide, Hadeel, Huggins, Gordon S., Beshansky, Joni R., Ruthazer, Robin, Peter, Inga, Ray, Madhab, Mukherjee, Jayanta T., Selker, Harry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668670/
https://www.ncbi.nlm.nih.gov/pubmed/26631004
http://dx.doi.org/10.1186/s12872-015-0153-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668670/
https://www.ncbi.nlm.nih.gov/pubmed/26631004
http://dx.doi.org/10.1186/s12872-015-0153-7

Ejemplares similares